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Noncoding RNAIt is known thatmore than 70% ofmammalian genomes are transcribed, yet the vastmajority of transcripts do not
code for proteins. Are these noncoding transcripts merely transcriptional noise, or do they serve a biological
purpose? Recent developments in genomic analysis technologies, especially sequencing methods, have allowed
researchers to create a large atlas of transcriptomes, study subcellular localization, and investigate potential inter-
actions with proteins for a growing number of transcripts. Here, we review the current methodologies available
for discovering and investigating functions of long noncoding RNAs (lncRNAs), which require a wide variety of
applications to study their potential biological roles. This article is part of a Special Issue entitled: Clues to long
noncoding RNA taxonomy1, edited by Dr. Tetsuro Hirose and Dr. Shinichi Nakagawa.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
1.1. Noncoding RNA
The central dogma of biology states that genetic information hard-
wired into DNA is transcribed into RNA and subsequently translated
into proteins. However, for several decades, scientists have noted the
existence and studied the function of RNAs that are not translated,
formally known as noncoding RNAs (ncRNAs) [1]. Molecules such as
transfer RNA (tRNA) and ribosomal RNA (rRNA), highly abundant
ncRNAs that primarily have structural and regulatory roles in transla-
tional machinery, represent notable and accepted exceptions to the
central dogma.
Since the initial discovery of tRNA and rRNAs in late 50's, a consider-
able number of other types of noncoding transcripts have been discov-
ered. Although functions and structures of tRNA and rRNAs were
revealed in the seventies, remaining noncoding RNAs have been largely
considered to be junk, debris, or side-products derived from the tran-
scriptional process, and whether they possess any biological meaning
has been long contended [2].
Beginning in the late nineties, several studies have started to focus
on what had been thought of as non-protein coding RNAs, such as onng noncoding RNA taxonomy1,
. This is an open access article underXist, and investigate the possibility that these molecules could possess
biological purpose. With recent developments in cDNA cloning and
sequencing technologies, scientists now estimate that up to 70–90% of
mammalian genomes are transcribed [3,4]. Intriguingly, less than 3%
of nuclear DNA is thought to be translated into proteins, leaving a vast
number of noncoding transcripts to be investigated [4].
Within the broad category of ncRNAs, scientists have grouped a num-
ber of transcripts that vary in length, localization, and function. In addi-
tion to the aforementioned tRNA and rRNA molecules, other classes of
relatively small ncRNAs such as small nuclear RNA (snRNA), small nucle-
olar RNA (snoRNA), piwi-interacting RNA (piRNAs), microRNA (miRNA),
and small interfering RNA (siRNA) have been identiﬁed (Fig. 1). These
small noncoding RNAs represent a wide spectrum of functional mole-
cules whose detailed discussion goes beyond the scope of this review.
Given such diversity, the current approach to studying ncRNAs is to fur-
ther classify these transcripts by size where noncoding transcripts longer
than 200 nucleotides (nt) in length are referred to as lncRNAs [5].
This review will focus on this particular class of transcripts, about
whichwe know relatively little, with a special emphasis on the technol-
ogies currently available for the discovery and validation of lncRNA
functions in cells. We will also provide examples of biological functions
discovered using these methodologies.
1.2. Long noncoding RNA
Many common characteristics between mRNAs and lncRNAs have
been observed. For instance, the majority of lncRNAs present similarthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Current annotation for the human (A) andmouse genomes (B). Loci are divided in three different categories – protein coding, pseudogene and non-coding – according to the latest
GENCODE releases, version 22 (October 2014 freeze, GRCh38) for the human genome and version M5 (December 2014 freeze, GRCm38) for the mouse genome. Non-coding genes are
further classiﬁed into long and small non-coding RNAs: lincRNA, long intergenic non-coding RNA; TEC, to be experimentally conﬁrmed transcript; asRNA, antisense RNA; miRNA,
microRNA; snRNA, small nuclear RNA; rRNA, ribosomal RNA; Mt. tRNA, tRNA located in the mitochondria genome; misc. RNA, miscellaneous other RNA; snoRNA, small nucleolar RNA;
scaRNA, small Cajal body-speciﬁc RNA; sRNA, small non-coding RNA.
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occurrence of trimethylation of lysine 4 of histone 3 (H3K4me3) and
the presence of RNA polymerase II (Pol II) binding sites [6] that serves
as an indicator of active transcription. Many lncRNAs also present
polyadenylation at their 3′ ends and possess 5′ caps [6]. However, in
contrast to mRNAs, a fraction of lncRNAs displays monomethylation of
lysine 4 of histone 3 (H3K4me1) marks, a signature of RNAs produced
by active enhancers [7].
Although expressed at lower levels than non-polyadenylated
mRNAs, lncRNAs without polyadenylation have also been found to
be very prevalent in the nucleus [8,9]. In fact, the number of non-
polyadenylated lncRNAs has very likely been underestimated whenanalyzing cDNA collections as the majority of studies have used
oligo(dT) primers for cDNA synthesis, which speciﬁcally select for
poly(A) + transcripts. Although some cDNAs are synthesized due to
internal priming of oligo(dT) in regionswhere the primers bind to inter-
nal, adenine-rich regions of transcripts instead of to the poly(A) tail, this
does not universally happen, altogether leading to underestimation of
poly(A)- transcripts. [9]. Many lncRNAs have also been reported to be
tissue-speciﬁc [10–12], a feature which makes their discovery more
difﬁcult.
In terms of sequence conservation across different organisms,
lncRNAs generally seem to not follow the same evolutionary constraints
as those of protein-coding genes [13] as many lack homologs across
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such as miRNAs, lncRNAs can fold in a more complex manner and
form secondary as well as tertiary structures to serve their functions
[14]. Therefore, it should be noted that the functional domains formed
upon folding within a lncRNA may be evolutionarily conserved instead
of their sequences [15]. Interestingly, lncRNA promoters have been
found to be more conserved than lncRNA exons and almost as con-
served as those of protein-coding genes [3,6].
Another notable characteristic of lncRNAs is that their regulation can
be driven by transposable elements [16,17]. Examples of such lncRNAs
include human Alu and mouse short interspersed element (SINE) B2
RNAs which are both transcribed by RNA polymerase III (Pol III) in re-
sponse to environmental stress and serve as transcriptional repressors
by directly targeting Pol II [18].
In contrast to miRNAs, which function mainly in the cytoplasmic
compartment as post-transcriptional regulators, lncRNAs are found
both in the cytoplasm and the nucleus [13,19,20], suggesting that they
might play a role in epigenomic modiﬁcation of chromatin and regula-
tion of gene expression.
Since the discovery of lncRNAs, numerous studies have revealed
multiple functions for such transcripts. For example, lncRNAs have
been shown to be involved in the transcription and translation of
mRNAs [21], the regulation of gene expression and splicingmechanisms
[22], and have also been implicated in imprinting and dosage compen-
sation [23] (Table 1). Furthermore, a link between aberrant expression
of lncRNAs and human diseases has been demonstrated as reviewed
in [24,25]. Thus, a better understanding of how lncRNAs function
could potentially improve upon our current knowledge of cell regulato-
ry networks and disease mechanisms.
Although the lack of sequence conservation in lncRNAs has histori-
cally made prediction of lncRNA function based on sequence analysis
alone difﬁcult, recent technological developments, especially those in
sequencing technologies, have provided multiple approaches to detect
and study lncRNAs.
2. Discovery of noncoding RNA
The initial step in the elucidation of lncRNA roles in the cell is indi-
vidual lncRNA identiﬁcation. As discussed previously, tissue speciﬁcity
and low expression levels make lncRNA discovery difﬁcult. Therefore,
it is necessary that appropriate choices in sample preparation and
experimental methodology are carefully made.
2.1. CDNA library and tiling arrays
One of the traditional methods of identifying lncRNAs has been to
create lists of transcripts after generation and sequencing of cDNATable 1
Examples of lncRNAs showing diversity of functions.
lncRNA Biological function Refs.
Antisense-Uchl1 Enhances translation without interfering with mRNA
expression level
[21]
Gomafu/MIAT Neuron-restricted expression; may hinder spliceosome
formation and affect the splicing of mRNAs by
sequestering splicing factors
[26]
Hotair HOX gene regulation via recruitment of PRC2 in order to
silence expression
[27]
Kcnq1ot1 Genomic imprinting [28]
PCAT-1 Promotes cell proliferation; target of PRC2 regulation [29]
lincRNA-p21 DNA damage response lincRNA; repressor in
p53-dependent transcriptional responses
[30]
Malat1 Affects transcriptional and post-transcriptional regulation
of cytoskeletal and extracellular matrix genes
[22]
Panda Transcription factor decoy; sequesters transcription factor
NF-YA
[31].
Xist Dosage compensation, genomic imprinting, inactivation of
X chromosome
[32]libraries. The ﬁrst large-scale catalog of putativemouse noncoding tran-
scripts originated from the FANTOMproject at RIKEN [33]where 60,770
full-length cDNAs underwent Sanger sequencing. The results revealed
15,000 novel transcripts of which more than 70% were noncoding. In
addition, over 2000 sense-antisense pairs were also found in this large
collection of transcripts. These pairs are often co-expressed and can
sometimes regulate each other at a transcriptional level [34]. In the sub-
sequent FANTOM3 project [3], the census of lncRNAs grew to 23,000
units, and it became apparent that up to 73% of genes have some sort
of antisense transcription.
Among those discovered was one lncRNA which is expressed in an
antisense orientation from the ubiquitin carboxyterminal hydrolase L1
(Uchl1) locus and contains both a motif complementary to the 5′ end
of the Uchl1 mRNA and a non-overlapping 3′ region that encodes for
SINEB2. Upon export from the nucleus, this RNA enhances translational
efﬁciency of paired coding mRNA without altering their expression
levels [21].
An alternative, classical discovery method has been to probe tran-
scripts on tiling arrays. These arrays hybridize cDNAs to microarray
slides carrying tiled oligonucleotides that can be designed to cover
non-repetitive sequences of speciﬁc chromosomes or, potentially, the
entire genome. An example of this approach is the identiﬁcation of tran-
scripts from four humanHOX gene clusters using a very high-resolution
tiling array with 400,000 overlapping probes, each 40 nt in length [27].
Polyadenylated transcripts from primary human ﬁbroblasts were hy-
bridized to tiling arrays, leading to the discovery of intergenic ncRNAs.
One such lncRNA was found to be transcribed in an antisense manner
within the HOXC gene and hence was named HOX antisense intergenic
RNA (HOTAIR). HOTAIR has been found to repress transcription across
40 kb of the HOXD locus on chromosome 2 in cis and to interact with
polycomb repressive complex 2 (PRC2) [27].
Tiling arrays can be designed at even higher resolutions to provide
in-depth analysis of alternative splicing, polymorphism discovery, and
novel transcription site identiﬁcation (as reviewed in [35,36]. In one
study, tiling arrays of 25mer oligonucleotides were used to analyze
RNAs produced from ten different human chromosomes. They were
designed such that the oligonucleotides were spaced every 5 bp. As a
result, each had a 20 bp overlap with its neighboring probe and thus
provided particularly high-resolution mapping of the RNAs [8]. In
addition, a large number of unannotated transcripts, many of which
were novel RNAs found exclusively in the nucleus, were identiﬁed by
separating poly(A) + and poly(A)- RNA fractions from the nuclear
and cytosolic compartments [8]. More than 40% of all RNAs were
found to be poly(A)-,withmore than half of nuclear poly(A)- sequences
having been derived from intronic regions [8].
Although useful for detecting and quantifying the expression levels
of transcripts originating from speciﬁc chromosomal regions, tiling
arrays have fallen into disuse since the emergence of next generation
sequencing (NGS) technologies.
This is due to the fact that themicroarray suffers frompotential noise
due to weak-binding or cross-hybridization of transcripts to probes,
which hinders the study of repetitive sequences, and also has a high
cost-beneﬁt ratio when searching through entire genomes.
2.1.1. High throughput sequencing serial analysis of gene expression
(SAGE)
SAGE was one of the ﬁrst methods for high-throughput analysis of
transcriptomes and is based on the generation of short stretches of
cDNA sequences (SAGE tags) containing recognition sites for restriction
enzymes at the 3′ end of transcripts [37]. SAGE tags are concatenated
before being cloned and subjected to Sanger sequencing. This method-
ology allows for both the quantiﬁcation of pre-annotated transcripts
and the identiﬁcation of new ones, a feature not previously possible
with microarrays alone.
The compilation of 272 SAGE experiments performed on normal and
cancerous human tissue samples revealed that lncRNAs are broadly
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somes [10]. Approximately 1% of the lncRNAs were ubiquitously
expressed across all investigated tissues, supporting the idea that most
lncRNAs function in a tissue-speciﬁc manner.
Although SAGE was once quite widespread, this sequencing-based
method has been replaced by NGS technologies, which proﬁle a larger
number of transcripts in greater depth. In addition, these newmethods
do not require tag concatenation, a step previously needed in order to
maximize the yield during Sanger sequencing.
2.1.2. RNA sequencing (RNA-seq)
RNA-seq is currently themost widespreadmethod used not only for
RNA expression detection, but also for novel lncRNA discovery. In addi-
tion to transcriptome proﬁling and discovery of novel transcripts [4],
RNA-seq can also be used for identifying alternative splicing isoforms
[38], single nucleotide polymorphisms [39], gene fusion events [40],
and novel splice junctions [41].
RNA-seq is based on the conversion of transcripts into a pool of
cDNAs that will constitute the sequencing library. In the early
stages of this technology, RNA-seq libraries were prepared with oligo
(dT) primers to enrich for poly(A) + RNAs and selectively deplete
non–polyadenylated RNAs, particularly rRNA. However, oligo (dT)
priming simultaneously excludes any non-polyadenylated or partially
degraded transcripts. To overcome this obstacle, various methods
using random primers for cDNA synthesis on rRNA-depleted transcripts
have been developed and standardized. Analysis of three different
mouse cell types – embryonic stem cells, neuronal precursor cells, and
lung ﬁbroblasts – revealed the presence of more than 1000 mouse
long intergenic noncoding RNAs (lincRNAs), the majority of which
had not been previously identiﬁed [42]. In another study, data analysis
of 24 human tissues and cell types yielded more than 8000 lincRNAs
[43]. Along with the identiﬁcation of large numbers of poly(A)-mRNA,
novel classes of lncRNAs which are generated from excised introns
have also been discovered [44]. We believe that this number is likely
to grow with advances in this technology.
A derivative technique, RNA capture sequencing, combines tiling ar-
rays with RNA-seq technology in order to increase the sequencing
depth of target regions [45]. First, tiling arrays are designed to probe
both coding and non-coding transcripts across several genomic regions.
Hybridized cDNAs are then eluted from oligonucleotide probes and
sequenced. By using this approach, multiple unannotated isoforms of
protein-coding RNAs and lncRNAs were identiﬁed in ﬁbroblasts [45].
In addition, a novel alternative splicing isoform of HOTAIR transcript
that lacks the binding domain for PRC2 was also discovered using RNA
capture sequencing.
2.1.3. Cap analysis of gene expression (CAGE)
CAGE is an alternative, high-throughput screeningmethod based on
NGS which allows for the simultaneous mapping and quantiﬁcation of
the expression of 5′-capped RNAs [46]. Compared to SAGE and RNA-
seq, this methodology proves an effective tool for the identiﬁcation of
transcriptionally active promoter regions and Pol II-driven transcription
start sites (TSS). However, as this method relies on 5′-capping of the
transcript, non-capped RNAs, such as many Pol III-driven transcripts,
and circular RNAs [47] cannot be detected. Furthermore, CAGE and
other RNAseq technologies often require a relatively large quantity of
starting RNA material. The recently developed nanoCAGE, however,
allows CAGE sequencing using a reduced number of starting cells [48]
and shows potential for single-cell transcriptional proﬁling [49]. This
technology also has a paired-read variant called CAGE-scan which
compensates for CAGE's inability to detect the 3′ end of transcripts by
reading in the vicinity of random-priming sites close to the middle of
the transcript. However, nanoCAGE requires a higher number of PCR
cycles and thus loses some of the ﬁne expression quantitation possible
with CAGE.In order to compare transcripts expressed genome-wide, Fort et al.
performed CAGE on human and mouse induced pluripotent stem
(iPS) cells, embryonic stem (ES) cells, and differentiated cells [19].
This led to the identiﬁcation of more than 4000 novel transcripts in
humans and 8000 in mice, which were named non-annotated stem
transcripts (NASTs) [19]. A large number of predominately nuclear
NASTs was transcribed from long terminal repeats, which constitute
either the promoters or the enhancers for these RNAs. In iPS and ES
cell lines, about 40% of these transcripts overlap regulatory regions
and associate with retrotransposon elements. A fraction of these unan-
notated lncRNAs may be produced by enhancers and super-enhancers,
an observation supported by Pol II chromatin interaction analysis with
paired-end tagging (ChIA-PET) data [50].
2.1.4. Detection of low-abundance transcripts/single-cell sequencing
Although sequencing technologies are highly powerful tools, occa-
sionally, sample sizes are insufﬁcient for RNA-sequencing such as when
conducting experiments on patient samples or using cells sorted with
ﬂuorescence activated cell sorting (FACS) [51]. In addition, heterogeneity
in levels of gene expression has been observed within same-cell popula-
tions [52]. Single-cell transcript sequencing methods allow detection of
heterogenic gene expression and can be used for small samples sizes.
Smart-seq [53] utilizes a full-length cDNA ampliﬁcation strategy,
SMART template switching technology, which allows detection of
alternative transcript isoforms and single-nucleotide polymorphisms.
Poly(A) + RNAs are reverse transcribed with tailed oligo (dT) priming
using cDNA synthesis primer and Moloney murine leukemia virus re-
verse transcriptase (MMLV RT). During ﬁrst-strand cDNA generation,
once the reverse transcription (RT) reaction reaches the 5′ end of a
template RNA molecule, the terminal transferase activity of MMLV
adds several non-template C nucleotides to the 3′ end of the cDNA.
This poly(C) overhang is used to synthesize the second strand, ensuring
only full-length cDNA are ampliﬁed in the ﬁnal round of PCR. After am-
pliﬁcation, puriﬁed cDNAs are sequenced. Although it is a useful tool,
Smart-seq is not strand-speciﬁc and may also be unable to read tran-
scripts which are longer than 4 kb [54].
DP-Seq is a method which allows ampliﬁcation of RNA from sample
sizes as small as 50 pg. The initial step of DP-seq is to design speciﬁc sets
of heptamer primers by taking into account the GC contents, the sec-
ondary structure of single-stranded cDNA, and the primers' proximity
to the 3′ end of the transcript [51]. In the original study, 44 heptamer
primers that amplifymore than 80% of themouse transcriptome, partic-
ularly unique regions, were designed. Next, enriched poly(A) + mRNA
underwent ﬁrst-strand cDNA synthesis followed by hybridization of
the designed primers and second-strand synthesis. PCR products were
then subjected to deep sequencing. Thismethodology suppresses highly
expressed ribosomal transcripts in RNA-sequencing libraries by more
than 70% and is able to detect low abundance transcripts which are
underrepresented in mES cells [51].
An alternative single-cell sequencing method which reduces
background noise is Quartz-Seq [55]. Synthesis of cDNA is carried
out in the presence of a RT primer containing a T7 promoter and PCR
target. Following degradation of the RT primer with exonuclease I, a
poly(A) tail is added to the 3′ end of the synthesized cDNA. After
second-strand synthesis with a tagging primer, the resulting cDNA con-
tains the whole-transcript ampliﬁcation adaptor sequences. These
cDNAs are further ampliﬁed using PCR in the presence of specially
designed suppression PCR primers in order to minimize unwanted
byproducts. The ﬁnal PCR product thus contains cDNAs with a T7
promoter sequence at their 3′ ends. These cDNAs can then be used for
Illumina sequencing and microarray experiments.
2.1.5. Parallel analysis of RNA-ends (PARE)/genome-wide mapping of
uncapped transcripts (GMUCT)/degradome-seq
RNA transcriptsmay be selected for degradation, and lncRNAs are no
exception. It has been known for several years that some lncRNAs may
7K. Kashi et al. / Biochimica et Biophysica Acta 1859 (2016) 3–15serve as templates tomiRNA, and that upon degradation, these lncRNAs
yield miRNA [56]. PARE-Seq [57], GMUCT [58], and degradome-seq [59]
have all been used to map transcripts which are in the process of being
degraded. In these methods, decapped transcripts are adapter-ligated
and reverse transcribed. Fragments are digested with MmeI to produce
a 20 nt tag before being puriﬁed, 3′-adapter-ligated, and ampliﬁed with
PCR, the products of which then undergo deep sequencing. PARE librar-
ies produced from various mouse tissues have identiﬁed small RNAs
which derived from mRNA, in both miRNA and non-miRNA-directed
cleavage pathway [60]. Interestingly, certain numbers of small RNAs
showed high homology to the lncRNA Xist, suggesting that regions of
Xistmay also be degraded to serve as templates for small RNA [60].
2.1.6. TIF-seq (transcript isoform sequencing)
TIF-seq allows identiﬁcation of both the 5′ and 3′ ends of transcripts
[61]. 5′ ends are decapped with tobacco acid pyrophosphatase (TAP)
and ligatedwith an oligonucleotide, a process known as 5′ oligocapping
[62]. Full-length cDNAs are produced by RT, ampliﬁed with PCR in the
presence of biotinylated primers, and circularized by intermolecular li-
gation. PCR products are then fragmented by sonication and sequenced
using paired-end reads. In S. cerevisiae, TIF-seq has been used to show
isoform heterogeneity in noncoding as well as coding genes with an av-
erage of sevenmajor unique transcript isoforms per stable unannotated
transcript.
2.1.7. Global run-on sequencing (Gro-seq)
RNA-seq and CAGE are both based on the analysis of steady state
RNA levels. To measure the half-life of transcripts at speciﬁc points
in time, the nuclear run-on assay and global run-on sequencing (GRO-
seq) methods were developed [63]. By sequencing nascent RNAs,
GRO-seq provides a genome-wide view of the location, orientation,
and density of Pol II-engaged transcripts at a high resolution. Extracted
nuclei undergo nuclear run-on assay in the presence of Br-UTP labeled
nucleotides and the detergent Sarkoysl, which releases paused Pol II,
to ensure that only engaged polymerases can produce labeled tran-
scripts, each of which are approximately 100 nt in length. Br-UTP-
tagged transcripts are captured with the antibody anti-Br-UTP and
subsequently undergo deep sequencing. This method speciﬁcally
reveals transcriptionally active loci with high sensitivity and can be
used for high-throughput, genome-wide applications in various organ-
isms. On the other hand, sample preparation, particularly the extraction
of nuclei and immunoprecipitation of Br-UTP-labeled RNAs, makes this
method technically challenging.
Previous studies using these methods have shown that Pol II often
initiates transcription divergently at active promoters and generates
antisense ncRNAs [64]. In human ES cells, Pol II-driven RNA molecules
are engaged immediately downstream of the TSS of protein-coding
gene and yield antisense lncRNA [65]. Furthermore, RNA-seq and
GRO-seq analyses have revealed that divergent transcription occurs at
the promoter area of active protein-coding genes. However, only a
small fraction of lncRNAs produced by such divergent transcription
is stable as divergent lncRNA transcripts are generally subjected to
exosome-mediated degradation [66].
2.1.8. 5′-bromo-uridine immunoprecipitation chase–deep sequencing
analysis (bric-seq)
BRIC-seq is a technique based on the hypothesis that the half-lives of
mRNAs or lncRNAs correlate with their physiological functions and reg-
ulation [67]. In contrast to GRO-seq, endogenous transcripts are labeled
by adding 5′-bromo-uridine (BrU) to cell culture media. Total RNAs
containing BrU-labeled RNAs (BrU-RNAs) are isolated at sequential
time intervals after removal of BrU from the culture medium. BrU-
RNAs are then recovered by immunopuriﬁcation, which is followed by
RT-qPCR or deep sequencing.
This method has been used to assess the RNA decay rates for
MALAT1 under physiological conditions in vivo [67]. Analysis of therelationship between RNA half-lives and their respective functional cat-
egories has shown that a signiﬁcant proportion of RNAs with half-lives
longer than four hours consist of ncRNAs (tRNAs, snoRNAs) and
mRNAs involved in housekeeping functions. Conversely, transcripts
with half-lives shorter than four hours primarily include regulatory
mRNAs and ncRNAs such as CDKN2B-AS1, HOTAIR, TUG1, and GAS5.
In addition, BRIC-seq on HeLa cells has also led to the discovery of 15
new lncRNAs, three of which are involved in cell proliferation and have
been named short-lived noncoding transcripts (SLiTs). The authors of
the study proposed that the half-life of a transcript is a key parameter
for selecting uncharacterized functional noncoding transcripts for
further study [67].
Although very effective for discovering new transcripts, high-
throughput screenings rely on the length and abundance of different
RNAs in the sequencing library and their mappability to the reference
genome [68]. As previously discussed, a known feature ofmany lncRNAs
is their fairly low expression levels [43]. Due to this, it has been estimat-
ed that approximately 700million reads are required to obtain accurate
quantiﬁcation ofmore than 95% of expressed transcripts [69]. Therefore,
sample extraction and preparation have to be optimized to enrich tar-
gets and minimize loss of desired lncRNAs. CAGE offers an alternative
sequencing method which detects only the promoter element and
thus likely requires fewer reads for similar detection efﬁciency. Never-
theless, further advances in sequencing technology are still required to
better understand the cell's transcriptome.
3. Function of noncoding RNA
Following the identiﬁcation of lncRNAs as summarized in Fig. 2, it is
necessary to determine if these transcripts indeed possess biological
functions. Perturbation of the expression of target RNAs – either by
overexpression or knockdown – is a common approach to studying
the physiological role of lncRNAs in the cell [70]. In this section, we re-
view alternative and complementary technologies to further ascertain
the biological function of these ncRNAs.
3.1. Localization: ﬂuorescence in situ hybridization (FISH)
Visualization of the subcellular localization of a given lncRNAby FISH
technology can shed light on the potential functions of noncoding
transcripts. In one study, RNA-FISH analysis of MALAT1 indicated that
it is abundant in the nuclear speckles of cells in interphase and is also
concentrated in mitotic interchromatin granule clusters, a structural
analog of nuclear speckles present in mitotic cells [22].
In another study, RNA-FISHwas used to detect Kcnq1, Kcnq1ot1, and
Xist in E12.4 placental sections and successfully showed that Kcnq1ot1
forms a domain in which genes located inside have the potential to be
epigenetically inactivated [28]. RNA-FISH can also be combined with
DNA-FISH to validate co-localization of a transcript with chromatin
sequences. However, FISH does not provide deep mechanistic insights
of lncRNAs, such as whether they function in cis or in trans due to its
limited resolution. More precise technologies that study the interaction
between lncRNA and chromatin will be discussed later in this article.
Alternatively, the recently introduced technology of ﬂuorescent in
situ RNA sequencing (FISSEQ) allows cDNA ampliﬁcation in cross-
linked cells and tissue samples [71]. This method provides higher reso-
lution and can identify a higher number of targets than RNA-FISH. Al-
though it has lower read counts when compared to standard RNA-seq,
this technology could potentially be used to visualize cell- or tissue-
speciﬁc gene expression and localization of lncRNAs.
3.2. Interaction: RNA–protein
Though lncRNA functions have yet to be widely elucidated, studies
have shown that lncRNAs play a signiﬁcant role in gene regulation
and that many likely interact with proteins in order to achieve their
Fig. 2.Overviewof various sequencingmethodologies used to discover lncRNAs. Schematic diagramof available technologies to detect RNA transcripts. Capped transcripts can be detected
by CAGE, nanoCAGE, or CAGE-scan. DP-seq, Smart-seq, and Quartz-seq are used to identify low-abundance transcripts. Rapidly degraded transcripts can be detected using PARE, GMUCT,
or Degradome-seq. Half-lives can be measured with Bric-seq. Any actively transcribed lncRNAs can be detected using Gro-seq.
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shown to form complexes with proteins known as ribonucleo-
protein particles [72]. As such, it would be reasonable to assume
that other lncRNAs might form similar complexes that affect pro-
teins' functions. Therefore, it is appropriate to extend the search for
other lncRNA–protein interactions. Knowledge of interacting part-
ners for certain transcripts might lead to new insights into their
potential biological functions in cells.
3.2.1. RNA immunoprecipitation (RIP)
RIP is used to purify RNAs associated with speciﬁc proteins by
directing antibodies against the target protein. Cross-linking of cells
prior to RIP is often not required, and as a result, the potential genera-
tion of artifacts is reduced. Pretreatment with DNase I and/or RNase H,
which digests the RNA in RNA–DNA hybrids, can help distinguish
between indirect binding,which occurs via neighboring DNA, and direct
binding. Alternatively, treatment with different nucleases can help de-
termine whether RNA interacts as a single strand or in stem-and-loop
conformation. Such investigation can identify RNA regions that interact
with proteins.
RIP was ﬁrst used to investigate which proteins interact with the
lncRNA Xist, a major player involved in X-chromosome inactivation
(XCI) [73] which is an essential biological phenomenon used for dosage
compensation of X-linked gene products in females. The lncRNAXist has
been identiﬁed as the initiator of XCI, whereas its antisense Tsix
functions as a repressor of Xist. The choice between which of the two
chromosomes is to be inactivated is random, and what distinguishes
between the inactive X (Xi) and active X (Xa) chromosomes is the
recruitment of the lncRNA Xist which is expressed exclusively by Xi
and accumulates around its locus in cis [74]. As Xist levels increase, the
chromatin structure undergoes structural modiﬁcations. The deletion
of Xist results in the loss of its nucleolar association and the inability to
maintain Xi heterochromatin. Although several hypotheses on Xist's
action mechanism were formulated, no study addressed the issue of
which proteins interact with Xist until RIP was used to discover that
the Eed, Suzl2 and RbAp48 proteins are all associated with Xist [75].
Repeat A (RepA) motifs, speciﬁc segments that are essential in
achieving inactivation, were shown to be the ﬁrst RNA regions to be
bound during the process of XCI. PRC2 was found to be recruited tothe X chromosome by the RepA region of Xist, while Ezh2 functioned
as an RNA-binding subunit. From these discoveries made using RIP, it
is apparent that RepA/PRC2 interaction is required for the initiation
and spread of XCI [75].3.2.2. High-throughput sequencing cross-linking immunoprecipitation
(HITS-CLIP)
HITS-CLIP, also known as CLIP-Seq, is another technique used to
identify RNA–protein interaction by cross-linking cells in vitro with
UV light. Unlike chromatin immunoprecipitation sequencing (ChiP-
Seq), where cross-linking is performed with formaldehyde (FA), the
UV radiation forms a covalent bond between RNA and amino acids.
After cross-linking and immunoprecipitation, RNAs are fragmented
with RNase before undergoing proteinase digestion and puriﬁcation.
CLIP-seq has been used to identify sets of lncRNAs bound to Ezh2
in human colorectal HCT116 cells [76]. Notably, several RNA se-
quences corresponding to intronic regions of chromatin-modifying
genes – histone methyltransferase genes SMYD3 and EHMT1, the chro-
matin remodeler gene ARID4A, and the polycomb-related genes EPC2
and RBBP4 – have been discovered as well. One of the limitations of
CLIP-seq is that it does not provide the full-length sequence of tran-
scripts, although the sections it does identify correspond to essential
protein-binding sites. Furthermore, UV cross-linking may change the
original sequence as mutations could occur during UV light exposure.
These drawbacks can be corrected when a comprehensive set of anno-
tated lncRNA sequences is available, but this remains a challenging task
for cell-speciﬁc, lowly expressed nuclear lncRNAs.
Another recent discovery made using CLIP is the characterization of
exon-intron circular RNA (EIciRNA). Here, CLIP was performed on Pol II
[77] as a large number of lncRNAs have been reported to be associated
with transcriptional regulation [78]. This led to the discovery of more
than 100 novel circular RNAs (circRNA) in HeLa and HEK293 cells. In
situ ﬂorescence hybridization has conﬁrmed their localization in the
nucleus. Unlike other circRNAs that are formed exclusively via exon-
backsplicing, newly identiﬁed Pol II-associated circRNAs retain unspliced
introns. Depletion of such EIciRNAs leads to the downregulation of the
parental mRNA, underscoring their role in transcription and/or stabiliza-
tion of the parental gene.
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noprecipitation (PAR-CLIP)
PAR-CLIP is a further modiﬁcation of the HITS-CLIP protocol which
provides improved cross-linking efﬁciency and higher nucleotide
read resolution. Hafner et al. initially introduced this method in
which photoreactive ribonucleoside analogs, 4-Thiouridine (4SU) and
6-thioguanosine (6SG), are applied to living cells to facilitate stronger
cross-linking between RNAs and proteins. The photoreactive analogs
undergo a structural change in response to cross-linking with UV-
lights and develop speciﬁc sequence mutations: T to C in 4SU, and G
to A in 6SG [79]. This allows detection of the speciﬁc binding sites of
RNA binding proteins and shows high resolution along with decreased
signal-to-noise ratio compared to other methodologies.
PAR-CLIP has also revealed the association of JARID2, another acces-
sory component of the PRC2 complex required for the differentiation of
ES cells, with several lncRNAs, including Meg3 [80]. More than 9000
putative RNA–protein contact sites for JARID2 have been identiﬁed
using PAR-CLIP. However, more than 50% of these identiﬁed sequences
contained repeat elements (RE), and due to the impossible nature
of mapping repetitive sequences to unique genomic regions, they
were subsequently discarded. However, we believe that these elements
should be further tested as retrotransposon elementsmay be functional
as promoters [16] or translation enhancers [21],
In addition to HITS-CLIP and PAR-CLIP, a third derivative approach to
identify protein–RNA interaction named individual-nucleotide resolu-
tion cross-linking and immunoprecipitation (iCLIP) has been intro-
duced [81]. Compared to the two previously described methods, iCLIP
can identify protein-binding sites at single-nucleotide resolution.
Protein–RNA complexes are immunoprecipitated and subjected to
proteinase K, which leaves only amino acids that are cross-linked to
the binding site. Unlike CLIP, RNAs are not subjected to 5'RNA adaptor
ligation, but instead undergo RT directly. During RT, binding sites with
intact amino acids will truncate cDNA synthesis. Therefore, read-
through cDNAs are synthesized if there are no cross-links or proteins
bound to RNA, and these can be further ampliﬁed with PCR and then
sequenced. By comparing truncated products against read-through
products, it is possible to determine protein-binding sites at single-
nucleotide resolution.
3.3. Interaction: RNA–DNA
LncRNAs that are thought to be involved in the regulation of gene
expression are often physically located on the chromatin, either indi-
rectly via a protein intermediate [82], or directly via hybridization,
which causes the formation of triple helices [83,84].
Although co-localization can be observed with DNA-RNA FISH,
higher resolution methods are needed to obtain more speciﬁc mecha-
nistic insights, and several technologies have been developed in order
to achieve this. We will introduce three recent developments that
share the common idea of probing speciﬁcally for lncRNAs of interest
to investigate their association with chromatin. The differences be-
tween these methods lie in the speciﬁc techniques used such as the
cross-linkingmethod and probe design.While theymay be very helpful
in mapping interactions between RNAs and chromatin, these methods
rely on probing for a speciﬁc lncRNA. Therefore, approaches that could
map such interactions in a genome-wide context are greatly needed.
3.3.1. Chromatin isolation by RNA puriﬁcation (ChIRP)
Previous methodologies have focused on the interaction between
ncRNAs and proteins where the primary goal is to determine which
ncRNAs are bound to the protein of interest. However, when the protein
complex is not known, ChIRP can identify associations between an RNA
of interest and chromatin [85]. Samples are cross-linkedwith formalde-
hyde, sonicated to generate smaller fragments, and then hybridized
with 20 nt-long biotinylated oligonucleotides which speciﬁcally
recognize the target lncRNA. As lncRNAs are known to fold and formthree-dimensional structures, it is difﬁcult to determine the open region
of such complexes. Thus, tiled oligonucleotides are designed to cover
the entire length of the sequence excepting repeat elements and regions
that are homologous to other sequences in the genome. This is essential
to ensure high speciﬁcity and sensitivity for the target RNA. Protein–
DNA–ncRNA complexes are thenwashed and puriﬁedwith streptavidin
magnetic beads. After the reversal of cross-links, nucleic acids can be
analyzedwith sequencing platforms to identify genomic regions associ-
ated with lncRNAs. NcRNAs can be quantiﬁed with qPCR, while associ-
ated proteins can be analyzed using Western blot. Using ChIRP,
Chu et al. isolated HOTAIR-associated DNA regions, demonstrating
that HOTAIR commonly nucleates at GA-rich DNA regions [85]. Further-
more, ChIRP has also been optimized to elute proteinswhich are further
analyzed with mass spectrometry [86]. This approach was used to
identify 81 new proteins bound to the Xist lncRNA [86].
3.3.2. RNA antisense puriﬁcation (RAP)
RAP is another technology which can be used to identify the geno-
mic regions of chromatin that interact with RNAs [87]. When compared
to ChIRP, RAP uses longer antisense RNA probes – 120 nt-long –which
ensures high-afﬁnity binding to the target lncRNA and a reduced signal-
to-noise ratio. As in ChIRP, RAP uses a pool of overlapping probes that
are tiled to cover the entire length of target transcripts except for repeat
elements, regardless of whether regions are unavailable for hybridiza-
tion due to steric hindrance. Isolated genomic DNA–RNA complexes
are then partially digested with DNase I to reduce the genomic DNA
fragments to 300 bp or fewer, the product of which can then be
sequenced using NGS. With this methodology, the precise binding
localization of Xist RNAs on the X chromosome during its inactivation
in mouse ES cells was identiﬁed [87]. Time course RAP analysis, com-
bined with three-dimensional chromatin conformation capture Hi-C
data [88,89], has shown that XCI is initiated at distal regions of the X
chromosome. The inactivation then gradually spreads fromeach contact
point, accompanied by modiﬁcation of the chromatin structure.
3.3.3. Capture hybridization analysis of RNA targets (CHART)
CHART utilizes a concept similar to that of ChIRP and RAP technolo-
gies as it involves the puriﬁcation of cross-linked protein, RNA, and DNA
complexes [90]. Thismethodology is based, however, on the use of short
afﬁnity-tagged oligonucleotides (C-oligos). Instead of creating large
numbers of probes for the entire length of the selected lncRNA in
order to capture target complexes, the probe design is focused around
the region of potential open binding sites. These are detected before-
hand by hybridization of oligos and RNase H mapping.
If the target lncRNA forms a secondary structure or binds to a
protein, then those stretches of RNAswill be occupied and thus inacces-
sible. C-oligos will only be able to bind to open regions and will then be
subjected to digestion by RNase H.
Once sensitive and speciﬁc regions have been identiﬁed with RNase
H mapping, biotinylated 24 nt-long C-oligos are designed. The ﬁnal
products recovered by CHART are the genomic regions and proteins to
which the target lncRNA binds. CHART was ﬁrst used to investigate
the function of roX2, a well-studied ncRNA involved in dosage compen-
sation in Drosophila [90], but was also later used to study Xist [91]. As
previously discussed, it had been shown that the RepA region of Xist
recruits PRC2 before Xist spreads over the X-chromosome for inactiva-
tion [92]. However, by performing time course analysis of CHART-seq,
it was concluded that Xist spreading takes two distinct, stage-speciﬁc
forms. Xist ﬁrst targets gene-rich clusters before spreading gradually
to gene-poor regions, a ﬁnding that was subsequently conﬁrmed with
with RAP [91].
To equalize X-chromosome dosages between the sexes, the female
mammal inactivates one of her two X-chromosomes. X-chromosome
inactivation (XCI) is initiated by expression of Xist, a 17-kb noncoding
RNA that accumulates on the X in cis. Because interacting factors have
not been isolated, the mechanism by which Xist induces silencing
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and identify the polycomb complex, PRC2, as its direct target. PRC2 is
initially recruited to the X by RepA RNA, with Ezh2 serving as the
RNA-binding subunit. The antisense Tsix RNA inhibits this interaction.
RepA depletion abolishes full-length Xist induction and H3-K27
trimethylation of theX. Likewise, PRC2 deﬁciency compromises Xist up-
regulation. Therefore, RepA/PRC2 is required for the initiation and
spread of XCI. We conclude that a ncRNA cofactor recruits polycomb
complexes to their target loci.
3.4. Interaction: RNA–RNA
Many ncRNAs interactwith other RNAs either directly through base-
pairing – often miRNA–mRNA or mRNA–lncRNA sense-antisense – or
indirectly through protein intermediates. The discovery of the associa-
tion of lncRNAs with proteins that regulate RNA processing [93,94]
suggests that these transcripts may target other RNAs as part of their
regulatory function [34].
3.4.1. Rap-rna
Modiﬁcation of the RAP method can provide a means to detect
RNA–RNA interactions. Speciﬁcally, it makes distinguishing direct
and indirect interactions between transcripts possible byusing different
cross-linking methods. Engreitz et al. have designed three different ap-
proaches, namely the RAP-RNA[AMT], RAP-RNA[FA], and RAP-RNA[FA-DSG]
techniques [95]. RAP-RNA[AMT] can be used to detect direct RNA–RNA
interaction by utilizing the cross-linker 4'aminomethyltrioxalen
(AMT), which generates speciﬁc uridine bases cross-links. This tech-
nique captures RNAs that bind directly to each other without the use
of a protein intermediate. On the other hand, FA, a commonly used
cross-linking agent, maintains RNA–protein interactions and allows ad-
ditional detection of RNA species which bind in an indirect fashion
(RAP-RNA[FA]). A combined treatment with FA and disuccinimidyl
glutarate (FA-DSG) can lead to even stronger cross-links between pro-
teins. Therefore, RAP-RNA[FA-DSG] is able to capture RNAs which are
bound via multiple protein intermediates, thereby detecting larger
complexes. Fragmentation is followed by protein digestion, capture
with biotinylated antisense oligonucleotide probes, and sequencing.
One study using RAP-RNA revealed that U1 snRNA directly hybridizes
to 5′ splice sites of its nascent RNAs and Malat1 was found to interact
with pre-mRNAs indirectly through protein intermediates [95].
3.4.2. Cross-linking, ligation and sequencing of hybrids (CLASH)
CLASHusesUV cross-linking as itsmethod of choice to capture direct
RNA–RNAhybridization [96]. As it uses UV light exposure, CLASH has an
advantage over chemically cross-linked cells in which protein–protein
cross-linking can occur, making it difﬁcult to distinguish direct interac-
tions from protein intermediate-mediated interactions. After afﬁnity
puriﬁcation of a protein of interest, the RNA molecules are ligated
together to generate chimeric RNAs and are ﬁnally sequenced. This
method led to the identiﬁcation of novel snoRNA–rRNA in yeast [96]
and miRNA–mRNA interactions associated with human Argonaute
[97]. Although this technology is relatively reliable in identifying RNA–
RNA interactions, its limiting step is the low ligation rate of RNAs [97],
a drawback which requires optimization. To our knowledge, this
technique has yet to be used to probe transcriptomes for lncRNA
interactions, and we foresee its potential to be used for applications of
this nature.
3.5. Secondary structure of lncRNA
In spite of the fact that a large number of lncRNAs has been identiﬁed
and their functions studied, we still lack understanding of how their
secondary and tertiary structures dictate speciﬁc interactions with pro-
teins or other nucleic acids. However, a few well-studied examples
highlight the importance of RNA structure in inferring their functionalmechanisms. RNA structural analysis of the RepA region of the Xist
locus, which contains eight to nine repeated elements, has revealed
two long stem-loop structures, each containing four REs. Interactions
formed between REs and spacers stabilize these stem-loops, and in
turn, the A region is able to associate with components of the PRC2
complex in mouse ES cell nuclear extracts [98]. Although a single four-
repeat motif was shown to be able to associate with components of
this complex, recruitment of Suz12 has shown a higher efﬁciency
when the entire A region is present [75].
Determination of the secondary structure of lncRNAs is often
hindered by the fact that the number of possible structures grows
exponentially with transcript length, hence affecting computational
approaches to predict the secondary structure. For example, it has
been estimated that for a 2.2 kb-long lncRNA, there are up to 10888
possible secondary structures [99]. Thus, these types of calculations
are impractical not only on a genomic scale, but even at the level of
individual RNAs. However, some recent studies have introduced
genome-wide approaches for probing for RNA secondary structures,
techniques which could potentially be extended to lncRNAs [14].
These studies use either chemical probing to acylate ﬂexible RNA
bases that do not participate in structural interactions or speciﬁc
enzymes that cleave structured and unstructured regions of RNAs.
3.5.1. Selective 2′ -hydroxyl acylation by primer extension (SHAPE)
SHAPE has enabled researchers to produce a large number of data on
the secondary structures of several RNAs. The reagents for SHAPE, such
as N-methylisotoic anhydride (NMIA) and 1-methyl-7-nitroisatoic
anhydride (1 M7), selectively modify RNA to form a 2′-O-adduct via a
nucleophilic attack. Reaction occurs more frequently with structurally
ﬂexible nucleotides such as single-stranded regions and loops, whereas
highly structured regions are conformationally constrained and there-
fore cannot be acylated. Modiﬁed positions are subsequently detected
by primer extension using target-speciﬁc primers. 2′-O-modiﬁed sites
inhibit the synthesis of cDNA, and as such, the extension length resem-
bles the distance between the primer binding and 2′-O-adduct sites.
Using this methodology, it has become possible to reveal the secondary
structure of the entire RNA genome of the human immunodeﬁciency
virus [100].
Although SHAPE is powerful for determining single- and base-paired
regions, it cannot provide information regarding whether the base-
pairing interactions act at close- or long-range [99]. To resolve this
issue, the shotgun secondary structure (3S) determination technique
uses fragmentation of RNA molecules followed by SHAPE analysis.
The proﬁle of fragmented transcripts are then compared against full-
length RNA SHAPE data [99], which allows a more detailed reconstruc-
tion of local folding along with the secondary structure of the
whole transcript [99]. Recently, a higher efﬁciency, click-selective 29-
hydroxyl acylation and proﬁling experiment (icSHAPE) protocol has
been introduced in vivo using a novel, bifunctional chemical probe
[101].
Analysis of RNA structural proﬁles of polyadenylated transcripts
in vivo and in vitro has revealed that pseudogenes, lncRNAs, and primary
miRNA precursors retain substantially more of their RNA structure
in vivo [101]. This is in accordance with previous studies that have
shown RNA structural signatures in vivo can be used to distinguish
between coding and structural or regulatory RNAs [101,102]. More
importantly, this approach shows the scalability of SHAPE and its
potential to generate a genome-wide representation of the secondary
structure of transcripts.
3.5.2. Fragmentation sequencing (frag-seq)
Many of the technologies discussed above have been designed to in-
vestigate the structure of RNAs of interest just one transcript at a time.
Frag-seq was developed in order to perform a genome-wide structural
analysis of transcripts [103]. Frag-Seq is a high-throughput RNA
structure probing method that uses NGS of RNA fragments generated
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stranded nucleic acids, making the identiﬁcation of the remaining
double strand regions and reconstruction of secondary structures possi-
ble. Underwood et al. probed the entire nuclear transcriptome from
mouse ES and differentiated neuronal precursor cells, conﬁrming the
presence of single-stranded regions for previously studied ncRNAs. In
addition, they were able to determine the previously unidentiﬁed
structure of U15b C/D box snoRNA [103]. Frag-Seq is a powerful tool
as a genome-wide predictor of RNA secondary structure. However,
fragmentation with nucleases makes determination of RNA secondary
structures at single-nucleotide level resolution challenging [104].
3.5.3. Parallel analysis of RNA structure (PARS)
Similar to Frag-seq, PARS involves the treatment of RNA pools with
structure-speciﬁc nucleases, but differs from Frag-Seq as to how the
transcript folding is mapped [105]. Speciﬁcally, RNA fragments are
generated by enzymes that cleave either single- or double-stranded
RNA regions, a process which is followed by conversion into cDNA and
deep sequencing. Kertesz et al. mapped the secondary structure of the
entire budding yeast transcriptome, determining the thermodynamic
stabilities of RNAs and characterizing structural elements of lncRNAs.
This approach also revealed a three-base structural motif across gene
bodies that correlates with translational efﬁciency. In addition, coding
regions were found to exhibit signiﬁcantly more pairing, whereas 5′
and 3′ UTRs were considerably less structured. This study also
conﬁrmed known structural motifs and structural properties of the
HOTAIR lncRNA.
Recently, PARS was also applied to a family trio (father, mother, and
child) and revealed the impact of genetic sequence variation on RNA
secondary structure and inherited structural patterns [102]. Interesting-
ly, approximately 15%of transcribed single nucleotide variants do in fact
alter RNA secondary structure. These transcripts named riboSNitches
include genetic variants that have been previously linked to human
diseases, suggesting that our current understanding of the impact of
mutations in the non-protein coding regions of the genome is still
inadequate.
Questions regarding a possible folding code for the function and role
of post-transcriptional modiﬁcation on folding in vivo remain unan-
swered. With these new technologies in hand, it might be possible to
gain a much needed understanding of the relationship between lncRNA
structure and the mechanisms of its actions.
4. Ribosome proﬁling: are some noncoding RNAs coding?
The above approaches have been used assuming lncRNAs are truly
non-protein-coding. However, aswas discussed earlier, there are highly
similar features between ncRNA and mRNA. Therefore, the possibility
that ncRNAs could in fact be protein-coding should be investigated.
Ribosome proﬁling [106] allows for the visualization of the direct
binding of transcripts to ribosomes and enables translational global
analysis. This technique involves the stabilization of RNA–ribosome in-
teractions with cycloheximide, which is followed by digestion of RNAs
not engaged by ribosomes. RNA fragments, protected fromRNases by ri-
bosomes, are then sedimented through a sucrose cushion based on size
and density [106,107]. Ribosomes are then degraded and the remaining
RNAs fragments are high-throughput sequenced. Depending on the di-
gestion conditions, thismethodwill yield fragmented transcripts of var-
ious sizes. A limitation for this technology is that it often recovers
relatively short fragments due to the size of ribosomal protection. This
causes further difﬁculties in mapping accuracy, particularly for short
and/or repetitive sequences, which are frequently found in ncRNAs. In
addition, as this methodology retrieves ribosome-RNA complexes
based on size, it naturally introduces biases such as the possibility of re-
covering RNAs protected by proteins other than ribosomal proteins.
Background RNA noise can be further resolved by targeting afﬁnity-tagged version of large subunit ribosomal protein L1 with RAP, thus en-
abling enrichment of actively translated genes [108].
LncRNAs associated with ribosomes have also been found in ribo-
some proﬁling data, and further experiments have shown that these
transcripts encode for short peptide-chains [109,110]. On the other
hand, a different study has shown that the frequency of lncRNAs en-
gaged by ribosomes is somewhat comparable to that of 5'UTRs of coding
genes [111], suggesting that simple ribosome occupancy does not imply
protein/peptides synthesis [111]. As previously discussed, the antisense
transcript of UCHL1 interacts with the protein-coding gene and en-
hances its translational rate [21]. We speculate that the antisense
transcript of UCHL1 could perform its function by directing the sense
mRNA to the polysomal fraction. Although the mechanisms are not
yet well understood, it may be possible that other ncRNA associated
with polysomes may regulate translation rather than being directly
translated.
The likelihood with which a presumed ncRNA could encode for a
peptide can also be calculated with the Coding-Potential Assessment
Tool (CPAT) [112], a software which analyzes the sequence features of
ORFs and also screens for the presence of known protein motifs within
a transcript's ORF [113]. However, in the FANTOM3 project [3], it was
observed that many of the short ORFs from lncRNAs produce peptides
without biologically active structures, indicating that even if peptides
could be synthesized, the likelihood they have biological function is
debatable.
However, there are a few instances in which hypothetical lncRNAs
have been found to encode functional short peptides, thus identifying
them as protein-coding mRNAs. For example, a previously unrecog-
nized ORF in a muscle-speciﬁc lncRNA was discovered. This lncRNA
possesses a 138 nt ORF with the potential to encode for a highly
conserved small peptide calledmyoregulin (MLN) [114]. MLN functions
in adult skeletal muscle as a dominant negative regulator of the calcium
pump SERCA located in the sarcoplasmic reticulum. This study high-
lights the existence of functional peptides produced by RNAs currently
thought to be noncoding.
Translating ribosome afﬁnity puriﬁcation (TRAP) was developed
to assess translational rate of mRNAs [115]. Genetically modiﬁed
mouse models are used to express enhanced green ﬂuorescent protein
(EGFP)-tagged ribosomal proteins, allowing the recovery of the popula-
tion of mRNAs which are associated with at least one 80S ribosome.
Using microarray analysis of transcripts bound to polysomes, TRAP
identiﬁes genes that are being actively translated. Since the emergence
of NGS technologies, TRAP can be used for genome-wide analysis.
Rpl10a-mCherry taggedmousemodels were used to study the translat-
ed RNA in vivo [116]. Interestingly, upon analysis of the translatome and
transcriptome of embryonic brains and kidneys, 85 RefSeq ncRNAs from
the brain and 60 from the kidney were found to be enriched in the
groups of translated RNA, suggesting that what have been grouped
into the ncRNA category could in fact be coding mRNAs. Yet, this
accounts for a relatively small proportion of the total number of
lncRNAs, indicating that themajority of what are thought to be lncRNAs
are likely to indeed be noncoding.5. Discussion/perspective
LncRNAs are becoming a hot topic in biology, particularly due to the
possibility that lncRNAs may provide multiple regulatory mechanisms
essential for mammalian homeostasis and development. Numerous
studies have also uncovered strong associations between abnormal
gene regulatory networks and pathologies [117]. In addition, lncRNAs
may help explain the diversity of complexity among organisms. While
the number of mammalian genes is quite close to that of simpler inver-
tebrates, mammals are far more complex animals, and it is the vast dif-
ference in the number of lncRNAs which could explain such surprising
differences in complexity [118].
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recent advances in sequencing technologies (Fig. 3). A growing number
of studies have been investigating the nature and functions of such
transcripts. For instance, perturbation experiments using overexpres-
sion and knockdown have revealed new and multiple roles for several
lncRNAs [19,76,119,120]. However, gene perturbationmay cause unex-
pected off-target effects, thus complicating the study of lncRNA func-
tions [121,122]. As a result, experiments involving lncRNAs require
appropriate replicas and controls. Recently, the bacterial clustered regu-
larly interspaced short palindromic repeats (CRISPR)/CRISPR-associated
9 (Cas9) system has emerged as a promising method of investigating
the function of genes [123]. CRISPR has been used to delete miR-21,
miR-29a, lncRNA-21A, UCA1, and AK023948 in human cell lines [124],
and Rian, a 23 kb maternally expressed lncRNA gene, in mice in vivo
[125]. As such, the CRISPR system may become an essential tool in
probing lncRNA function in the future.
The CRISPR system could also be applied to the relocalization
of lncRNAs to study their functions, a possibility introduced with
CRISPR-Display (CRISP-Disp) [126]. Nuclease-deﬁcient Sp. Cas9 mutant
(dCas9) complexes deploy large RNA cargos to speciﬁc, targeted DNA
loci. The advantage of this technology is that upon optimization, there
is no obvious limitation in the size of RNA that can be loaded. Further-
more, these RNA-based functions can be targeted at multiple points
using a shared pool of dCas9, in turn widening ranges of functional
analysis [126].
CRISP-Disp can also be used to answer the question of whether
lncRNAs achieve their functions due to being transcribed from a speciﬁc
locus, or if the transcripts themselves have speciﬁc functional motifs.
CRISP-Dispwas applied in thismanner to two known eRNA: focally am-
pliﬁed longnon-codingRNA in epithelial cancer (FALEC) and translation
regulatory long non-coding RNA 1 (TRERNA1). In this study, the eRNAs
were individually loaded upstream of the luciferase reporter gene. It
was found that TRERNA1 was able to activate reporter gene, whereas
FALEC failed, suggesting that the conformational interaction of the
FALEC gene locus with the target gene region may be required for
activation [126]. Furthermore, it was demonstrated with activating
lncRNAs that speciﬁc motifs are necessary to recruit the transcription
initiation complex [126].
Current studies focus primarily on lncRNAexpression in the total cell
population. We foresee that in the future, more work will need to beFig. 3.Overview of different technological approaches to study functions of lncRNAs. Schematic
nucleus of eukaryotic cells, DNA (red) is wrapped around histone proteins (blue). Long non-c
chromatin modifying proteins (green) and regulate gene expression. Technologies focused on
also bind to other proteins (orange), and such interactions can be studied with RIP, CLIP, PAR
study RNA–RNA interactions between different lncRNAs. lncRNAs can fold into complicated
Transcripts which are actively translated or associated with ribosomes (blue) can be detectedperformed on lncRNA expression at the single-cell level. As Bumgarner
et al. have shown in yeast, there is variation in the expression levels
of the lncRNAs CR1 and PWR1 in individual cells [127]. In addition,
lncRNAs have been shown to contribute to differences in the expression
of FLO11 [127]. Moreover, single-cell RNA-seq has also revealed dynam-
ic changes in lncRNA expression during cell reprogramming [128].
Recently, many studies have identiﬁed functions for several ncRNAs;
however, the question as to whether all lncRNAs have biological
purposes still stands. Pervasive transcription has been observed in eu-
karyotes ranging from yeast to humans [129]. Still, many transcripts
are present at very low levels, an observation that could be explained
by the fact that ncRNAs are degraded soon after transcription [130].
One of the key arguments for the functionality of lncRNAs is their
tissue speciﬁcity. However, an alternative explanation for such phe-
nomena is that the high concentration of transcription factors could
bind to accessible DNA regions in order to reach a critical mass and
therefore permit the binding of RNA polymerase. [130]. Depletion of
Rrp6p, a protein involved in the degradation of RNA in the nucleus,
leads to increased levels of Pol II- and Pol III-driven ncRNAs, suggesting
that some ncRNAs may simply be transcriptional noise [131].
Therefore, functional analyses have to be performed thoroughly in
order to determine whether lncRNAs indeed have functional roles in
the cell. Gene perturbation, such as overexpression or downregulation,
followed by RT-qPCR or deep sequencing is needed to observe changes
in gene expression. Again, if differentially expressed genes are observed,
other complicating factors such as sequencing depth and off-target
effects must be considered carefully before any conclusions can be
drawn. With our current knowledge, it is impossible to easily predict
from sequence alone whether a speciﬁc lncRNA is functional. As previ-
ously discussed, it may be the three-dimensional structure of lncRNA
and not the sequence itself which is signiﬁcant.
Given the growing number of newly identiﬁed transcripts, we
speculate that not all lncRNAs will have clearly demonstrable functions
in cells and laboratory animals, particularly when the screening is
performed on cell lines rather than under the physiological conditions
of living organisms. Some ncRNAs may not have measurable functions
under experimental conditions, but could become functional under
environmental stress, a feature which would provide the organism
with an evolutionary reservoir for adaptation. Combined with issues
in phenotype screening, the lack of measurable functions could also bediagram of available technologies to study actionmechanisms for different lncRNAs. In the
oding RNAs (red) can mediate locus-speciﬁc epigenetic modiﬁcations by interaction with
DNA–RNA interactions (ChIRP, CHART, and RAP) can map such cross talks. lncRNAs can
-CLIP, and ChIRP methodologies. RAP, CLASH, or ChIRP technologies can be employed to
secondary structures that can be mapped with SHAPE, 3S, FRAG, or PARS approaches.
using ribosome proﬁling or Trap-seq.
13K. Kashi et al. / Biochimica et Biophysica Acta 1859 (2016) 3–15due to limitations in technological ability to knockdown or overexpress
lncRNAs. We argue that with the emergence of new tools—especially
those in the ﬁeld of phenotype assessment and genome editing—to
study ncRNA functions in cells, researchers will be able to advance
knowledge of this family of transcripts.Conﬂict of interest
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